SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new ...
Please provide your email address to receive an email when new articles are posted on . The FDA cleared two AI algorithms to evaluate the success of PVI ablation for complex arrhythmias. These tools ...
The Brighterside of News on MSN
Origami 3D printed belt uses AI to spot dangerous heart rhythms in real time
Rising rates of heart rhythm problems are colliding with an aging population and crowded hospitals. At the same time, many ...
Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced new study data demonstrating that there ...
New research can transform how hospitals triage, risk-stratify, and counsel patients to save lives. Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) ...
iRhythm Technologies reports high prevalence of cardiac arrhythmias in type 2 diabetes patients associated with chronic kidney disease, highlighting early detection importance. iRhythm Technologies, ...
New ACC/AHA guidelines provide updated management strategies for the growing population of adults living with congenital heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results